Unibest

Pharmaceutical intermediates

Pemafibrate Intermediates

2 pharmaceutical intermediates for Pemafibrate. Indication: Hyperlipidemia.

提交项目All intermediates

About Pemafibrate

Originator
Kowa Co., Ltd.
Indication
Hyperlipidemia

Available intermediates

2 intermediates currently listed for Pemafibrate. Request specifications, documentation or a quotation for any item below.

Pemafibrate intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
n-butyl (S)-2-trifluoromethanesulfonyl-oxybutanoate907192-60-3//
3-(4-methoxyphenoxy)propan-1-amine100841-00-7//

Other programs under P

PacritinibPalbociclibParecoxib sodiumParicalcitolPaxlovidPazopanib HydrochloridePeficitinib HydrobromidePeramivir

Building toward Pemafibrate?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →